ConductScience.org, home

Trial · NCT02039219

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
TreatmentSTARTEDPlacebo11
TreatmentSTARTED10 mg Obeticholic Acid (OCA)8
TreatmentCOMPLETEDPlacebo7
TreatmentCOMPLETED10 mg Obeticholic Acid (OCA)6
TreatmentNOT COMPLETEDPlacebo4
TreatmentNOT COMPLETED10 mg Obeticholic Acid (OCA)2
Follow upSTARTEDPlacebo7
Follow upSTARTED10 mg Obeticholic Acid (OCA)6
Follow upCOMPLETEDPlacebo7
Follow upCOMPLETED10 mg Obeticholic Acid (OCA)5
Follow upNOT COMPLETEDPlacebo0
Follow upNOT COMPLETED10 mg Obeticholic Acid (OCA)1

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02039219/flow